Načítá se...
How can we minimise the use of regular oral corticosteroids in asthma?
Options to achieve oral corticosteroid (OCS)-sparing have been triggering increasing interest since the 1970s because of the side-effects of OCSs, and this has now become achievable with biologics. The Société de Pneumologie de Langue Française workshop on OCSs aimed to conduct a comprehensive revie...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
European Respiratory Society
2020-02-01
|
Edice: | European Respiratory Review |
On-line přístup: | http://err.ersjournals.com/content/29/155/190085.full |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|